Debut
PrivateLast Round
VC Round
Aug 26, 2025
Total Funding Raised
$105.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Debut operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a VC Round in August 2025.
Debut is a biotechnology company that develops advanced cell-free biomanufacturing platforms and AI-driven discovery tools to produce sustainable, high-performance bioactive ingredients for the cosmetics and skincare industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Sustainable Materials, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Debut Comparables
Compare Debut with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enzymit | 84% | |
| Cambrium | 83% | |
| Arcaea | 82% |
For institutional investors. Book with your work email.
Debut Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 26, 2025 | ||||
| Series B | Oct 19, 2023 | ||||
| Series B | Jun 12, 2023 | ||||
| Series A | Aug 12, 2021 | ||||
| Seed | Jan 7, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Debut Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Better Ventures | Seed |
| Fine Structure Ventures | Series A, Series B, VC Round |
| FTW Ventures | Seed |
| Cultivian Sandbox Ventures | Series A, Series B |
| GS Futures | Series B, VC Round |
| Cantos Ventures | Series A |
| Cavallo Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Natura is now using its ingredients in products.
- Jul 15, 2026
L'Oréal is now using its ingredients in products.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 25, 2026
In Jul '25, Debutbiotech, Inc. partners with L'Oréal to develop fermentation-based ingredients for beauty and personal care products, supporting sustainable alternatives and bio-based formulation technologies.
For institutional investors. Book with your work email.
Debut Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Debut's valuation, stock price, and market status.
Is Debut a public or private company?
Debut is a private company.
What is the current stock price of Debut?
Debut is a private company, so its shares have no public market price. Caplight tracks Debut's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Debut worth (valuation)?
Valuation information for Debut is not publicly available.
Can I buy Debut stock?
Debut shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Debut's last funding round?
Debut's most recent funding round was VC Round on August 26, 2025.
Who are the main investors in Debut?
Key investors in Debut include Material Impact, BOLD (Business Opportunities for L'Oréal Development), KdT Ventures.
Will Debut IPO soon?
No public IPO plans have been announced for Debut.
How can I track Debut secondary market activity?
Caplight tracks bids, offers, and trades in Debut's shares on secondary markets.